PMID- 21276434 OWN - NLM STAT- MEDLINE DCOM- 20120312 LR - 20131121 IS - 1872-6240 (Electronic) IS - 0006-8993 (Linking) VI - 1386 DP - 2011 Apr 22 TI - Tumor necrosis factor-alpha (TNF-alpha) augments AMPA-induced Purkinje neuron toxicity. PG - 1-14 LID - 10.1016/j.brainres.2011.01.059 [doi] AB - It is well recognized that exposure of neurons to excessive levels of the excitatory neurotransmitter glutamate, termed glutamate excitotoxicity, contributes to the damage and degeneration seen in many acute and chronic neurological diseases. However, it is becoming increasingly evident that inflammation also can play a role in certain neurodegenerative diseases and inflammatory mediators, such as tumor necrosis factor-alpha (TNF-alpha), may directly interact with excitotoxic processes. In a postnatal rat cerebellar slice model, we found that TNF-alpha exacerbated AMPA-induced excitotoxicity in Purkinje neurons in a dose-dependent manner beyond the toxicity caused by AMPA alone. It also was shown that combinations of TNF-alpha and AMPA increased the mean intracellular activity of calpains, calcium-activated cysteine proteases that are known to contribute to cell death in Purkinje neurons. Additionally, these combinations augmented colbalt influx, a marker for calcium entry that selectively occurs through calcium permeable AMPA receptors only. Pharmacologic blockade of calcium permeable AMPA receptors with a specific antagonist, 1-naphthyl acetyl spermine (NASPM), reversed the apparent increase in AMPA receptor calcium permeability caused by TNF-alpha as measured by cobalt influx; caused a reduction in the Purkinje neuron calpain activity; and reversed the enhanced neurodegeneration induced by the combination of TNF-alpha and AMPA. From these studies we concluded that TNF-alpha augmented AMPA-induced toxicity in Purkinje neurons by increasing intracellular calcium flux through calcium permeable AMPA receptors, and this increase in calcium was directly involved in enhanced activation of calpains and a greater percentage of Purkinje neuron loss. CI - Copyright (c) 2010 Elsevier B.V. All rights reserved. FAU - Bliss, Richard M AU - Bliss RM AD - Department of Cell Physiology and Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. FAU - Finckbone, Velvet Lee AU - Finckbone VL FAU - Trice, Jacquelyn AU - Trice J FAU - Strahlendorf, Howard AU - Strahlendorf H FAU - Strahlendorf, Jean AU - Strahlendorf J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110126 PL - Netherlands TA - Brain Res JT - Brain research JID - 0045503 RN - 0 (Inflammation Mediators) RN - 0 (Neurotoxins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 77521-29-0 (alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Animals, Newborn MH - Calcium/metabolism MH - Calcium Signaling/drug effects/physiology MH - Inflammation Mediators/*physiology MH - Nerve Degeneration/chemically induced/*metabolism/*pathology MH - Neurotoxins/agonists/toxicity MH - Organ Culture Techniques MH - Purkinje Cells/drug effects/*metabolism/*pathology MH - Rats MH - Rats, Sprague-Dawley MH - Tumor Necrosis Factor-alpha/*physiology MH - Up-Regulation/*physiology MH - alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/agonists/*toxicity EDAT- 2011/02/01 06:00 MHDA- 2012/03/13 06:00 CRDT- 2011/02/01 06:00 PHST- 2010/09/17 00:00 [received] PHST- 2011/01/17 00:00 [revised] PHST- 2011/01/19 00:00 [accepted] PHST- 2011/02/01 06:00 [entrez] PHST- 2011/02/01 06:00 [pubmed] PHST- 2012/03/13 06:00 [medline] AID - S0006-8993(11)00143-0 [pii] AID - 10.1016/j.brainres.2011.01.059 [doi] PST - ppublish SO - Brain Res. 2011 Apr 22;1386:1-14. doi: 10.1016/j.brainres.2011.01.059. Epub 2011 Jan 26.